The Austin Technology Incubator (ATI) is the deep technology incubator of UT Austin. We nurture startups founded around scientific and engineering breakthroughs, particularly in healthcare and sustainability. For over 30 years ATI has served UT faculty, researchers, and students at many stages in their entrepreneurship journey with programs including ATI membership, NSF I-Corps, Texas Global Health Security Innovation Consortium, TEX Venture Mentoring Service, and Student Associate experiences.

Membership in the Austin Technology Incubator is open to early-stage "deep tech" startups from inside and outside UT. By deep tech we mean scientific and engineering breakthroughs, particularly in healthcare and sustainability. Membership provides a uniquely customized experience including ongoing expert support, connections to capital, access to testing and prototyping labs, and in-depth student projects. Members usually join when they have working technology and are preparing to raise money.

The Kendra Scott Women’s Entrepreneurial Leadership Institute (KS WELI) supports creatives, founders, leaders, and allies by redefining leadership and entrepreneurship. KS WELI equips and empowers students of all backgrounds through engaging programming and events, spotlighting women-led businesses through the Founder Program, and sponsoring interdisciplinary courses within the McCombs Entrepreneurship Minor. Since its founding, KS WELI has become a force on UT’s campus to grow and support the number of women-owned and women-led businesses.

The Corporate Relations team is uniquely suited to help connect UT's research and innovation with relevant and interested company partners. We seek to solicit and raise funding from companies to advance student programming, research and discovery. If UT students or faculty would like to explore developing/deepening ties with industry, we suggest that we first have an internal discussion to assess the opportunity so that we can make appropriate connections.

The Office of Technology Commercialization (OTC) is the only organization on campus authorized to manage university-owned IP (trademarks excepted). The OTC works with researchers to define the technology, assess its development stage, strategize potentially valuable patent claims, and as necessary, file patents to protect the IP in advance of publication. The OTC also supports technologies that are not patentable, such as software and copyrighted works that may be commercialized via license.

The Office of Technology Commercialization helps UT researchers monetize software and creative content they develop while at the university. The Office of Technology Commercialization can help researchers find the optimal license type and distribution strategy for such work, which includes open sourcing. The Office of Technology Commercialization also helps with finding commercialization partners, negotiating licenses, and supporting startups.

A 9-week summer accelerator program that picks the most promising emerging UT startups (undergrad, grad, and faculty teams) and helps them confront their next market-driven milestone. In its 13th year, alumni companies have collectively raised $100M and generated over $400M in valuation.

The Texas McCombs M.S. in Technology Commercialization (MSTC) program was the first ever go-to-market graduate program in the U.S. Designed as a launchpad for your businesses and products, MSTC gives you everything you need to take your ideas to market either through a venture of your own or an existing organization. A top-ranked, STEM-designated degree, MSTC remains one of the most popular and diverse programs for innovative working professionals who want to break into the market.

The Texas Global Health Security Innovation Consortium (TEXGHS) connects academic, public- and private-sector partners to support companies working towards pandemic preparedness and response in Texas. TEXGHS is developing a health security innovation ecosystem that supports innovators and innovations fighting COVID-19 and future pandemics. UT Austin entrepreneurs should contact TEXGHS when they are seeking to commercialize infectious disease-related innovations at any stage of development.

Texas Health Catalyst supports the translation of promising ideas and discoveries into solutions that improve health outcomes and lower health care costs. The program provides support through timely and customized guidance on the research and development pathway from industry and clinical experts (Phase 1 awards), as well as seed funding for awardees (Phase 2 awards of $5K-$50K per project).